ID   KKU-023
AC   CVCL_VF98
SY   KKU023
DR   cancercelllines; CVCL_VF98
DR   JCRB; JCRB1778
DR   Wikidata; Q54900001
RX   PubMed=29110582;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 34.8 hours (PubMed=29110582).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=29110582).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): JCRB
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 10,13,14
ST   D5S818: 10,12
ST   D7S820: 8,10,11
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 17,21,22
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 05-10-23; Version: 11
//
RX   PubMed=29110582; DOI=10.1177/1010428317725925;
RA   Saensa-ard S., Leuangwattanawanit S., Senggunprai L., Namwat N.,
RA   Kongpetch S., Chamgramol Y., Loilome W., Khansaard W., Jusakul A.,
RA   Prawan A., Pairojkul C., Khantikeo N., Yongvanit P.,
RA   Kukongviriyapan V.;
RT   "Establishment of cholangiocarcinoma cell lines from patients in the
RT   endemic area of liver fluke infection in Thailand.";
RL   Tumor Biol. 39:1010428317725925-1010428317725925(2017).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//